Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sharmila Dorbala, M.D.

Co-Author

This page shows the publications co-authored by Sharmila Dorbala and Rodney Falk.
Connection Strength

13.939
  1. Transthyretin cardiac amyloidosis in patients with severe aortic stenosis. Eur Heart J. 2020 08 01; 41(29):2768-2770.
    View in: PubMed
    Score: 0.925
  2. Evaluating Prognosis in AL Amyloidosis: Can LV Strain Play a Role? JACC CardioOncol. 2020 Jun; 2(2):232-235.
    View in: PubMed
    Score: 0.917
  3. An antibody against pre-amyloid oligomers: a potential clinical tool or merely an intriguing observation? Eur Heart J. 2020 03 21; 41(12):1271-1272.
    View in: PubMed
    Score: 0.902
  4. How to Image Cardiac Amyloidosis: A Practical Approach. JACC Cardiovasc Imaging. 2020 06; 13(6):1368-1383.
    View in: PubMed
    Score: 0.875
  5. Imaging cardiac amyloidosis: Patient page. J Nucl Cardiol. 2019 02; 26(1):217-221.
    View in: PubMed
    Score: 0.825
  6. Apical to Base Gradient of Technetium-99m Pyrophosphate Myocardial Counts in Cardiac Amyloidosis: An Insight Into the Mechanism of Myocardial Strain Gradient, or Merely "Clouds That Mimic Land Before the Sailor's Eye?" JACC Cardiovasc Imaging. 2018 02; 11(2 Pt 1):243-246.
    View in: PubMed
    Score: 0.758
  7. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. J Am Coll Cardiol. 2016 09 20; 68(12):1323-41.
    View in: PubMed
    Score: 0.708
  8. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail. 2014 Aug; 2(4):358-67.
    View in: PubMed
    Score: 0.608
  9. Imaging cardiac amyloidosis: a pilot study using ¹8F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014 Sep; 41(9):1652-62.
    View in: PubMed
    Score: 0.602
  10. How to image cardiac amyloidosis. Circ Cardiovasc Imaging. 2014 May; 7(3):552-62.
    View in: PubMed
    Score: 0.600
  11. Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis. Eur J Nucl Med Mol Imaging. 2011 Mar; 38(3):467-9.
    View in: PubMed
    Score: 0.482
  12. Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2021 Aug; 28(4):1761-1762.
    View in: PubMed
    Score: 0.248
  13. Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. J Nucl Cardiol. 2021 Aug; 28(4):1763-1767.
    View in: PubMed
    Score: 0.248
  14. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. Circ Cardiovasc Imaging. 2021 Jul; 14(7):e000030.
    View in: PubMed
    Score: 0.247
  15. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. Circ Cardiovasc Imaging. 2021 Jul; 14(7):e000029.
    View in: PubMed
    Score: 0.247
  16. Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2021 Aug; 28(4):1769-1774.
    View in: PubMed
    Score: 0.247
  17. nAddendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Card Fail. 2021 Jun 25.
    View in: PubMed
    Score: 0.246
  18. Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2020 Sep 11.
    View in: PubMed
    Score: 0.233
  19. Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CT. J Nucl Med. 2021 05 10; 62(5):716-722.
    View in: PubMed
    Score: 0.233
  20. Complexities and Pitfalls in Cardiac Amyloidosis. Circulation. 2020 07 28; 142(4):409-415.
    View in: PubMed
    Score: 0.231
  21. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? JACC Cardiovasc Imaging. 2020 06; 13(6):1325-1336.
    View in: PubMed
    Score: 0.228
  22. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. J Nucl Cardiol. 2020 04; 27(2):659-673.
    View in: PubMed
    Score: 0.226
  23. Geographic variation in public interest about amyloidosis in the United States and English speaking countries. Amyloid. 2020 09; 27(3):210-212.
    View in: PubMed
    Score: 0.224
  24. Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis. Semin Nucl Med. 2020 07; 50(4):295-310.
    View in: PubMed
    Score: 0.224
  25. Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. Eur J Nucl Med Mol Imaging. 2020 07; 47(8):1998-2009.
    View in: PubMed
    Score: 0.221
  26. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2019 12; 26(6):2065-2123.
    View in: PubMed
    Score: 0.221
  27. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using 18F-Florbetapir PET/CT. J Nucl Cardiol. 2019 Nov 22.
    View in: PubMed
    Score: 0.221
  28. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. J Card Fail. 2019 Nov; 25(11):854-865.
    View in: PubMed
    Score: 0.217
  29. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. J Card Fail. 2019 Nov; 25(11):e1-e39.
    View in: PubMed
    Score: 0.217
  30. Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States. Circ Heart Fail. 2019 06; 12(6):e005407.
    View in: PubMed
    Score: 0.214
  31. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT. J Nucl Med. 2019 09; 60(9):1234-1239.
    View in: PubMed
    Score: 0.211
  32. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nucl Cardiol. 2019 02; 26(1):158-173.
    View in: PubMed
    Score: 0.207
  33. Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis. JAMA Cardiol. 2018 09 01; 3(9):865-870.
    View in: PubMed
    Score: 0.203
  34. Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits. JACC Cardiovasc Imaging. 2019 07; 12(7 Pt 1):1165-1173.
    View in: PubMed
    Score: 0.202
  35. True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis. Haematologica. 2018 08; 103(8):e374-e376.
    View in: PubMed
    Score: 0.197
  36. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study. Circ Cardiovasc Imaging. 2015 Aug; 8(8).
    View in: PubMed
    Score: 0.164
  37. Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans. Eur J Heart Fail. 2021 Aug; 23(8):1290-1295.
    View in: PubMed
    Score: 0.061
  38. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 06 09; 75(22):2851-2862.
    View in: PubMed
    Score: 0.057
  39. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14; 133(24):2404-12.
    View in: PubMed
    Score: 0.043
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.